Navigation Links
Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
Date:5/21/2010

ity/running around excessively, arguing with adults, and losing temper.  INTUNIV is a non-scheduled medication and has no known potential for abuse or dependence.   INTUNIV is available in US pharmacies in four dosage strengths:  1 milligram (mg), 2 mg, 3 mg, and 4 mg.  

INTUNIV Co-Administered With a Stimulant Demonstrated Significant Symptom Improvement vs. Stimulant Alone

This 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-optimized phase III study enrolled patients aged 6 to 17 years with a diagnosis of ADHD and suboptimal response* to treatment with a long-acting stimulant.

Throughout the study, patients continued to take their same once-daily dose of a long-acting stimulant and were randomized to three treatment arms:  INTUNIV dosed in the morning, INTUNIV dosed in the evening, or placebo.  A total of 455 patients were evaluated for efficacy and safety.  The study consisted of 5 weeks of dose optimization and 3 weeks of dose maintenance.  INTUNIV was optimized up to 4 mg per day.  

The primary efficacy analysis was the change from baseline in ADHD-RS-IV total score at end point.  ADHD-RS-IV is a standardized test for evaluating symptoms of ADHD and assessing response to treatment.   At baseline, mean ADHD-RS-IV total scores were 37.6, 37.0, and 37.7 for the INTUNIV AM/stimulant, INTUNIV PM/stimulant, and placebo/stimulant treatment groups, respectively.  At study end, mean ADHD-RS-IV total scores were 17.3, 16.1, and 21.7, respectively.  Placebo-adjusted least squares (LS) mean change from baseline at end point for ADHD-RS-IV total score was a decrease of 4.5 (P=.002) for the INTUNIV AM/stimulant and a decrease of 5.3 (P<.001) for the INTUNIV PM/stimulant.

In this s
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
2. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
3. New Study Shows ENJUVIA® Significantly Reduced Sleep Time Awakenings Caused by Hot Flashes in Postmenopausal Women
4. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
5. Whistleblower Lawyers Comment on New England Journal of Medicine Study
6. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
7. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
8. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
9. Spiral Enteroscopy is Three Times Faster than Double-Balloon Enteroscopy in Diagnosing the Small Intestine, New Study Finds
10. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
11. BetterInvesting Magazine Releases Julys Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... the Netherlands , May 5, 2015 ... lower esophageal sphincter (LES) stimulation therapy for gastroesophageal ... and efficacy results. The results demonstrated an excellent ... regurgitation and the "gold-standard" esophageal acid exposure (measured ... of dependence on daily PPI medications. ...
(Date:5/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/9pthtm/home_healthcare ) has ... Market - Forecast to 2020" report to their ... to reach more than $300+ billion growing at a ... equipment market is expected to grow at a faster ... is gaining a tremendous attention over hospitals for the ...
(Date:5/5/2015)... Calif., May 5, 2015 Isis Pharmaceuticals, Inc. ... income of $4.0 million for the three months ended ... operating loss of $22.6 million for the same period ... to higher revenue from milestone payments earned from its ... a GAAP basis, Isis reported a loss from operations ...
Breaking Medicine Technology:Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 13
(Date:5/6/2015)... TX (PRWEB) May 06, 2015 The ... opened its first freestanding emergency room in Chandler on ... Health Arizona General Hospital, which is also part of ... celebrate the grand opening, Dignity Health Arizona General Hospital ... Chandler Chamber of Commerce and donated $5,000 to Campo ...
(Date:5/6/2015)... London, England (PRWEB) May 06, 2015 ... exploding with new drinks. Little Miracles organic tea and ... by natural Panax ginseng and sweetened with agave, these ... popular consumer movement that seeks healthier ways to hydrate. ... 6, Little Miracles invites people to raise a bottle ...
(Date:5/5/2015)... (PRWEB) May 06, 2015 Social Media ... Make Social Media Your Most Powerful Marketing Tool and ... Washington, DC, http://www.fdanews.com/SocialMedia , Social media … ... of social media’s reach. Patients are using it — ... doctors about what they’ve discovered. , But, it can ...
(Date:5/5/2015)... May 05, 2015 With the FCPX LUT: ... quickly and easily add washed color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 90 washed CUBE LUT files. , This plugin ... can give any footage a washed look. , CUBE ...
(Date:5/5/2015)... UAE (PRWEB) May 05, 2015 Private ... , FZ LLC has announced that its dental stem ... for Store-A-Tooth™ increased once again--in April, 2015 –and posted ... month of increased record volume and represents a significant ... Provia’s dental stem cell biobank is conducted via the ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3
... Obama and Secretary of State Clinton on today,s nomination of ... Global AIDS Coordinator (OGAC). AIDS Action is pleased that ... by such an accomplished HIV medical expert with extensive knowledge ... the epidemic here in the United States. We encourage ...
... , Incorporated, a leading provider of business ... services, continues to expand its portfolio of innovative ... RACSource, a financial management and appeals analysis ... SOURCECORP ,s extensive experience in denial management, ...
... Indian Oncologists Are Starting to Embrace Use of ... a Report from Decision Resources WALTHAM, Mass., April ... leading research and advisory firms focusing on pharmaceutical ... brand/generics (oxaliplatin) and Roche/Chugai,s Xeloda, Indian brand/generics (capecitabine) ...
... WASHINGTON, April 28 First quarter federal reports ... provisions of the federal economic stimulus act, contradicting ... report of its effort was "100 percent false."Google,s ... lobbying during the period including on "online health-related ...
... Mich., April 28 Richard E. Smith, M.D., an ... as the 144th president of the Michigan State Medical ... MSMS House of Delegates meeting in Grand Rapids. (Logo: ... first African American to serve as MSMS president, will ...
... university Karolinska Institutet have shown that rapid diagnostic tests ... healthcare in low and mid-income countries in the fight ... a simple blood test and, according to the results, ... receive the right treatment at no extra cost for ...
Cached Medicine News:Health News:AIDS Action Applauds Selection of Dr. Eric Goosby as Global AIDS Coordinator 2Health News:SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense 2Health News:Sanofi-Aventis' and Roche/Chugai's Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 2Health News:Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giant's Denials 3Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 2Health News:Richard E. Smith, M.D., Installed as President of Michigan State Medical Society 3Health News:Simple blood test proves powerful ally in the fight against malaria 2
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: